… shown to be effective in patients with cytokine storm syndromes [Citation66], and further …
alternative for the treatment of cytokine release syndrome in patients with COVID-19 [Citation67]. …

… cytokine storms play an important role in severe COVID-19 cases. Therefore, neutralising
key … factors in cytokine release syndrome (CRS) will be of great value in reducing mortality in …

… (ARDS), had higher levels of inflammatory cytokines. The … like COVID-19, is described as
cytokine release syndrome (CRS… an increased level of cytokines that are released from myeloid …

… The 30-day mortality … disease and mortality. Viral load did not have prognostic significance
in our sample, suggesting that outcomes were chiefly driven by a cytokine release syndrome (…

… antagonist is considered as an immunosuppressant which impairs the immune response
to the infection and possibly increases mortality in the late stage of patients with COVID-19.…

… It was selected for its scientific pathophysiologic plausibility and potential utility in treating
CRS (including in COVID-19 patients), increased morbidity and mortality using glucocorticoids …

… with ACovCS and cytokine release syndrome in COVID-19, with a … associated with mortality
and critically ill pneumonia in COVID-19: … with increased mortality in patients with COVID-19. …

… study was aimed to assess the efficacy and safety of tocilizumab (TCZ) and to investigate
the factors related to the progress and mortality of patients with a secondary cytokine release …

… Large randomized clinical trials in severe Coronavirus Disease 2019 (COVID-19… mortality
of patients with tocilizumab administration in COVID-19 associated cytokine release syndrome …

… For future epidemic preparedness and to reduce mortality in COVID-19 patients, global
effort is needed to promote novel therapy to treat virus-induced CRS during the …